Sivem-Irbesartan/HCT Product Recall (2021-05-26)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Sivem-Irbesartan/HCT 150/12.5 mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| JP2979, JP2980, JU8206, JU8207 | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
| B. Sivem-Irbesartan/HCT 300/12.5 mg Tablet | DIN 02385325 | Tablet | Irbesartan 300 mg |
| JX8881, JX8882, JB0216 | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
| C. Sivem-Irbesartan/HCT 300/25 mg Tablet | DIN 02385333 | Tablet | Irbesartan 300 mg |
| JN5054, JV2163, JY7867,KT2519, KT2520 | - Recalling Firm
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
- Marketing Authorization Holder
- Sivem Pharmaceuticals ULC
- 4705 Dobrin Street
- St. Laurent
- H4R 2P7
- Quebec
- CANADA
| Sivem-Irbesartan/HCT 150/12.5 mg Tablet | DIN 02385317 | Tablet | Irbesartan 150 mg |
-
Sivem-Irbesartan/HCT 150/12.5 mg Tablet
-
Sivem-Irbesartan/HCT 300/12.5 mg Tablet
-
Sivem-Irbesartan/HCT 300/25 mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.